Tenet (THC) Reports Q2 Earnings: What Key Metrics Have to Say

Core Insights - Tenet Healthcare reported revenue of $5.1 billion for the quarter ended June 2024, reflecting a year-over-year increase of 0.4% and surpassing the Zacks Consensus Estimate of $4.98 billion by 2.49% [5][1] - The company achieved an EPS of $2.31, significantly higher than the previous year's $1.44, resulting in an EPS surprise of 22.22% compared to the consensus estimate of $1.89 [5][1] Revenue Breakdown - Net Operating revenues totaled $5.10 billion, exceeding the three-analyst average estimate of $4.96 billion [3] - Ambulatory Care revenues were reported at $1.14 billion, surpassing the average estimate of $1.05 billion, with a year-over-year growth of 21.1% [3] - Hospital Operations and other revenues reached $3.96 billion, slightly above the average estimate of $3.91 billion, with a year-over-year increase of 1% [3] Earnings Metrics - Equity in earnings of unconsolidated affiliates was reported at $61 million, exceeding the average estimate of $53.96 million [3] - Adjusted EBITDA for Hospital Operations and other was $498 million, compared to the average estimate of $466.58 million [3] - Adjusted EBITDA for Ambulatory Care was $447 million, surpassing the average estimate of $383.64 million [3] Stock Performance - Tenet's shares have returned +2.8% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [4] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [4]